4.7 Article

Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

Petra Steinacker et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Editorial Material Clinical Neurology

A revision of the El Escorial criteria-2015

Albert Ludolph et al.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015)

Article Clinical Neurology

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

Stefan Lehnert et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)

Review Clinical Neurology

Controversies and priorities in amyotrophic lateral sclerosis

Martin R. Turner et al.

LANCET NEUROLOGY (2013)

Editorial Material Clinical Neurology

Opportunity and innovation in studying pre-symptomatic amyotrophic lateral sclerosis

Michael Benatar et al.

MUSCLE & NERVE (2013)

Review Clinical Neurology

The epidemiology of ALS: a conspiracy of genes, environment and time

Ammar Al-Chalabi et al.

NATURE REVIEWS NEUROLOGY (2013)

Article Multidisciplinary Sciences

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

Johanna Gaiottino et al.

PLOS ONE (2013)

Review Clinical Neurology

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

Markus Otto et al.

AMYOTROPHIC LATERAL SCLEROSIS (2012)

Article Medicine, General & Internal

Amyotrophic lateral sclerosis

Matthew C. Kiernan et al.

LANCET (2011)

Article Clinical Neurology

Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

A Petzold

JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)